Kolon Life Science Inc (102940) — Capital Reinvestment Ratio
Latest as of September 2025:
3.12x
Kolon Life Science Inc (102940) has a Capital Reinvestment Ratio of 3.12x as of September 2025, meaning it reinvests 3% of its operating cash flow (₩2.58 Billion) in capital expenditures (₩8.05 Billion). See free cash flow generation of Kolon Life Science Inc to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
3.12x
Capex / Operating Cash Flow
Operating Cash Flow
₩2.58 Billion
KRW
Capital Expenditures
₩8.05 Billion
KRW
Data as of
Sep 2025
Most recent filing
Kolon Life Science Inc Capital Reinvestment Ratio (2011–2016)
This chart tracks Kolon Life Science Inc's Capital Reinvestment Ratio across 5 annual periods.
Annual Capital Reinvestment Ratio for Kolon Life Science Inc (2011–2016)
Year-by-year Capital Reinvestment Ratio for Kolon Life Science Inc from 2011 to 2016. For live market cap and broader valuation context, see Kolon Life Science Inc (102940) market capitalisation.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2016 | 0.57x | ₩28.11 Billion | ₩16.14 Billion | ▼ -21.5% |
| 2015 | 0.73x | ₩20.81 Billion | ₩15.22 Billion | ▼ -41.1% |
| 2014 | 1.24x | ₩12.10 Billion | ₩15.01 Billion | ▼ -52.5% |
| 2012 | 2.61x | ₩23.37 Billion | ₩61.01 Billion | ▲ +10.5% |
| 2011 | 2.36x | ₩11.65 Billion | ₩27.52 Billion | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow